Sign in
DFFN Stock Price, Chart, Stats & News
Diffusion Pharmaceuticals Inc.
Save
8.98M
Market cap
–
Current P/E
–
Forward P/E
DFFN chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -117.86% |
ROE | -96.04% |
D/E | – |
Interest coverage ratio | – |
DFFN valuation
P/E | – |
P/S | – |
P/B | 2.18x |
P/CF | -1.70x |
P/FCF | -0.38x |
P/OCF | -1.70x |
PEG | 0.01x |
EV multiple | -0.62x |
About
As a biopharmaceutical enterprise, Diffusion Pharmaceuticals Inc. concentrates on pioneering new treatments that bolster the body's efficiency in oxygen distribution. The company's flagship investigational therapy is Trans Sodium Crocetinate, which is formulated to facilitate the spread of oxygen into tissues. This compound is additionally under development for its application in addressing COVID-19.
Similar securities
Based on sector and market capitalization
Report issue